Hydromer, Inc. and Medinol Ltd. Enter Into A Coating Services And Supply Agreement For Stent Placement Catheters

Branchburg, NJ - Hydromer, Inc. announces that it has entered into a 3-year Coating Services and Supply Agreement with Medinol Ltd., a Medical Device Company that develops and manufactures innovative cardiovascular stents and catheters.

Under the terms of this self-renewing agreement, Hydromer has agreed to apply its proprietary and patented Hydromer hydrophilic coatings on various Pebax plastic stent placement catheters under strict FDA cGMP and ISO 13485-2003 conditions. Additionally, Medinol has the option to activate a license to apply this unique Hydromer coating technology on their cardiovascular catheters in facilities under Medinol's control worldwide.

"We are delighted with our new relationship and with having our Hydromer coating technology applied to Medinol's stent delivery catheters," commented Martin von Dyck, Executive Vice President of Hydromer, Inc., adding, "Medinol is known worldwide for their creativity and medical device innovations, thus Medinol's selection of Hydromer is an honor."

SOURCE: Hydromer, Inc.